Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Top Cited Papers
- 26 August 2007
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 25 (9), 1035-1044
- https://doi.org/10.1038/nbt1328
Abstract
Nature Biotechnology journal featuring biotechnology articles and science research papers of commercial interest in pharmaceutical, medical, and environmental sciences.Keywords
This publication has 44 references indexed in Scilit:
- Chemoproteomics-driven drug discovery: addressing high attrition ratesDrug Discovery Today, 2006
- Rational design of inhibitors that bind to inactive kinase conformationsNature Chemical Biology, 2006
- The Purinome, a Complex Mix of Drug and Toxicity TargetsCurrent Topics in Medicinal Chemistry, 2006
- Analysis of drug-induced effect patterns to link structure and side effects of medicinesNature Chemical Biology, 2005
- A small molecule–kinase interaction map for clinical kinase inhibitorsNature Biotechnology, 2005
- Strategies to overcome resistance to targeted protein kinase inhibitorsNature Reviews Drug Discovery, 2004
- Fishing for targets: novel approaches using small molecule baitsDrug Discovery Today: Technologies, 2004
- From magic bullets to designed multiple ligandsDrug Discovery Today, 2004
- The Protein Kinase Complement of the Human GenomeScience, 2002
- Protein kinases — the major drug targets of the twenty-first century?Nature Reviews Drug Discovery, 2002